Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)
Teva reaches $523M agreement with New York in latest opioid-related settlement
Teva has been working on making headway with its planned national settlement over its role in the US opioid epidemic. And it has one less …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
